|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
��,��״ϸ�� |
|
��,����ϸ�� |
|
���ʽ�������ø |
| ��������������� | |
|
���� |
|
������ |
| PubMed | |
|
Article by |
|
Article by |
Ƥ����״ϸ�����ͻ���ϸ�������ʽ�������ø��Ｐ��������ת�ƵĹ�ϵ
����, ������
�㶫ҽѧԺ����ҽԺƤ���� տ�� 524001
���ʽ�������øͨ������ϸ������ʺͻ���Ĥ�ɷ֡��ƻ��ֲ���֯�ṹ�����������յ���Ѫ���γɶ���������չ����Ϯ�ĸ����ξ�����Ҫ����;��������ø��֯�������Ӿ��п�Ѫ���γɼ����ڻ��ʽ�������ø���Ե�����,�Ӷ�����������Ϯ��ת�ơ�����֯�л��ʽ�������ø����ϵ���Ƥ����״ϸ�����ͻ���ϸ������һ������,��������ø��֯��������-2���ˮƽ��������ƤԴ��Ƥ��������������Ϯ��ת�������ʸ���ء�
[2] Dumas V, Kanitakis J, Charvat S, et al. Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas. Antieancer Res, 1999, 19(4 B) :2929-2938.
[3] O-Charoenrat P, Rhys-Evans PH, Eceles SA. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg, 2001, 127:813-820.
[4] Airola K, Fusenig NE. Differential stromal regulation of MMP-1 expression in benign and malignant keratinocytes. J Invest Dermatol,2001, 116:85-92.
[5] Imanishi Y, Fujii M, Tokumaru Y, et al. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.Hum Pathol, 2000, 31:895-904.
[6] Airola K, Johansson N, Kariniemi AL, et al. Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J Invest Dermatol, 1997, 109:225-231.
[7] Sehgal I, Thompson TC. Novel regulation of type IV collagenase (matrix metalloproteinase-9 and-2) activities by transforming growth factor-betal in human prostate cancer cell lines. Mol Biol Cell, 1999,10:407-416.
[8] Johansson N, Airola K, Grenman R, et al. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol, 1997, 151:499-508.
[9] Kerkela E, Ala-aho R, Lohi J,et al. Differential patterns of stromelysin-2 (MMP-10) and MTl-MMP (MMP-14) expression in epithelial skin cancers. Br J Cancer, 2001, 84:659-669.
[10] Kerkela E, Ala-Aho R, Jeskanen L, et al. Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer. J Invest Dermatol, 2000, 114:1113-1119.
[11] Yoshizaki T, Maruyama Y, Sato H, et al. Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma. Iht J Cancer, 2001,95:44-50.
[12] Tsukifuji R, Tagawa K, Hatamochi A, et al. Expression of matrix metalloproteinase-1,-2 and-3 in squamous cell carcinoma and actinic keratosis. Br J Cancer, 1999, 80:1087-1091.
[13] Varani J, Hattori Y, Chi Y, et al. Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin. Br J Cancer, 2000, 82:657-665.
[14] Tsukifuji R, Sakai Y, Hatamochi A, et al. Gene expression of matrix metalloproteinase-1 (interstitial collagenase) and matrix metalloproteinase-3 (stromelysin-1) in basal cell carcinoma by in situ hybridization using chondroitin ABC lyase. Histochem J, 1997, 29:401-407.
[15] Majmudar G, Nelson BR, Jensen TC, et al. Increased expression of stromelysin-3 in basal cell carcinomas. Mol Carcinog, 1994, 9:17-23.
[16] Wagner SN, Ruhri C, Kunth K, et al. Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma. Diagn Mol Pathol, 1992, 1:200-205.
[17] Thewes M, Worret WI, Engst R, et al. Stromelysin-3 (ST-3):immunohistochemical characterization of the matrix metalloproteinase(MMP)-11 in benign and malignant skin tumours and other skin disorders. Clin Exp Dermatol. 1999. 24:122-126.